Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Atenolol with calcium channel blocker
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tenif 50mg/20mg modified-release capsules
0204000U0BCAAAA
|
Tenif | Atenolol with calcium channel blocker | Cardiovascular System | 751 |
|
Atenolol 50mg / Nifedipine 20mg modified-release capsules
0204000U0AAAAAA
|
Atenolol/nifedipine | Atenolol with calcium channel blocker | Cardiovascular System | 517 |
|
Beta-Adalat modified-release capsules
0204000U0BBAAAA
|
Beta-Adalat | Atenolol with calcium channel blocker | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.